PRF Technologies PRFX
NASDAQ PRFX
$1.00 -0.01 (-0.99%)
At close: Aug 20, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2025)

PRF Technologies' (PRFX) quarterly Liabilities and Shareholders Equity came in at $12.0 million in Q4 2025, up 165.15% YoY from $4.5 million in Q4 2024, and up 7.49% on a QoQ basis from $11.2 million in Q2 2025.

PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $12.0 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 165.15% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.8 million (up 129.96% YoY) and the FY2025 annual result came in at $12.0 million, up 165.15% from the prior year.
  • Liabilities and Shareholders Equity rose to $12.0 million in Q4 2025, from $11.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.4 million in Q1 2021 to a low of $389000.0 in Q4 2023.
  • A 5-year average of $12.2 million and a median of $12.0 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity surged 2267.3% — and 2023, when it slumped 96.84%.
  • Tracing PRFX's Liabilities and Shareholders Equity over 5 years: stood at $19.1 million in 2021, then sank by 35.36% to $12.3 million in 2022, then tumbled by 96.84% to $389000.0 in 2023, then soared by 1063.24% to $4.5 million in 2024, then surged by 165.15% to $12.0 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $12.0 million (Q4 2025), $11.2 million (Q2 2025), and $4.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 PRF Technologies 654,452.72 -3.49 Mn - 12.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 12.00 Mn
Jun 30, 2025 11.16 Mn
Dec 31, 2024 4.53 Mn
Jun 30, 2024 3.11 Mn
Mar 31, 2024 5.37 Mn
Dec 31, 2023 389,000.00
Sep 30, 2023 10.89 Mn
Jun 30, 2023 8.32 Mn
Mar 31, 2023 10.42 Mn
Dec 31, 2022 12.33 Mn
Sep 30, 2022 14.85 Mn
Jun 30, 2022 15.99 Mn
Mar 31, 2022 17.71 Mn
Dec 31, 2021 19.07 Mn
Sep 30, 2021 20.34 Mn
Jun 30, 2021 19.84 Mn
Mar 31, 2021 21.35 Mn
Dec 31, 2020 17.80 Mn
Jun 30, 2020 838,000.00
Dec 31, 2019 1.16 Mn